Responses to COVID-19 Vaccines Vary in Patients With Hematologic Malignancies
Responses varied according to patients’ cancer type, the anticancer treatment they received, and which vaccine was used. this content first…
Responses varied according to patients’ cancer type, the anticancer treatment they received, and which vaccine was used. this content first…
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not. this content…
A lack of mask mandates at cancer centers and elsewhere has left cancer patients feeling unsafe and abandoned by society.…
Global registry data suggest that children with cancer have a higher risk of severe illness and death from COVID-19 when…
Cancer patients have been underrepresented in clinical trials of COVID-19 vaccines, so it hasn’t been clear how well the vaccines…
Patients with hematologic malignancies are known to be at risk of severe outcomes from COVID-19, and experts have recommended prioritizing…